• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 69-83 of 105 results

1006 Exhibit: Ex 1006 PCT International Publication No WO2013010868 to Barf, et...

Document IPR2023-00478, No. 1006 Exhibit - Ex 1006 PCT International Publication No WO2013010868 to Barf, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1030 Exhibit: Ex 1030 Tjeerd Barf, et al

Document IPR2023-00478, No. 1030 Exhibit - Ex 1030 Tjeerd Barf, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1041 Exhibit: Ex 1041 LYNPARZA™ olaparib Prescribing Information

Document IPR2023-00478, No. 1041 Exhibit - Ex 1041 LYNPARZA™ olaparib Prescribing Information (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1002 Exhibit: Ex 1002 Declaration Of John P Fruehauf, MD, PhD

Document IPR2023-00478, No. 1002 Exhibit - Ex 1002 Declaration Of John P Fruehauf, MD, PhD (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Prosecution History of US Patent No 10,272,083 Part 3

Document IPR2023-00478, No. 1004-3 Exhibit - Ex 1004 Prosecution History of US Patent No 10,272,083 Part 3 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Prosecution History of US Patent No 10,272,083 Part 5

Document IPR2023-00478, No. 1004-5 Exhibit - Ex 1004 Prosecution History of US Patent No 10,272,083 Part 5 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1016 Exhibit: Ex 1016 IMBRUVICA™ ibrutinib Prescribing Information

Document IPR2023-00478, No. 1016 Exhibit - Ex 1016 IMBRUVICA™ ibrutinib Prescribing Information (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1032 Exhibit: Ex 1032 Sarah Brumskill, et al

Document IPR2023-00478, No. 1032 Exhibit - Ex 1032 Sarah Brumskill, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1021 Exhibit: Ex 1021 Daniel W Pierce, et al

Document IPR2023-00478, No. 1021 Exhibit - Ex 1021 Daniel W Pierce, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1017 Exhibit: Ex 1017 US Food and Drug Administration Office of Clinical Pharmac...

Document IPR2023-00478, No. 1017 Exhibit - Ex 1017 US Food and Drug Administration Office of Clinical Pharmacology (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1038 Exhibit: Ex 1038 ZYDELIG® idelalisib Prescribing Information

Document IPR2023-00478, No. 1038 Exhibit - Ex 1038 ZYDELIG® idelalisib Prescribing Information (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1042 Exhibit: Ex 1042 Betty Y Chang, et al

Document IPR2023-00478, No. 1042 Exhibit - Ex 1042 Betty Y Chang, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1022 Exhibit: Ex 1022 Simon Rule, et al,

Document IPR2023-00478, No. 1022 Exhibit - Ex 1022 Simon Rule, et al, (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1034 Exhibit: Ex 1034 Plaintiffs’ Initial Infringement Contentions to Def Sandoz Inc

Document IPR2023-00478, No. 1034 Exhibit - Ex 1034 Plaintiffs’ Initial Infringement Contentions to Def Sandoz Inc (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 Prosecution History of US Patent No 9,758,524 Part 2

Document IPR2023-00478, No. 1023-2 Exhibit - Ex 1023 Prosecution History of US Patent No 9,758,524 Part 2 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 >>